New Drug Pricing Fight Pits Politics vs Patients
March 30, 2026·about 4 hours ago·via The Pharma Letter

A fresh battle erupts over drug affordability, blending pricing pressures, political posturing, and patient needs in Washington. Big Pharma faces heat from government meddlers pushing price controls that stifle innovation and hike costs long-term. Conservatives warn this reeks of socialist overreach, threatening the free-market miracles that deliver life-saving meds. Patients deserve affordable care without bureaucrats dictating terms or crushing companies that fuel our economy. Read more about this...